When administering a medication via IV push, which steps are essential for safe technique?

When administering a medication via IV push, which steps are essential for safe technique?

• A. Use aseptic technique, flush with saline before and after each med, administer slowly per order, monitor for adverse reactions.
• B. Use clean technique without sterile supplies, administer quickly, monitor for adverse reactions.
• C. Use aseptic technique, do not flush, administer rapidly, monitor only for bleeding.
• D. Keep IV line open by using a saline lock and avoid flushing before administration.

Answer: (A)

Safe IV push technique hinges on aseptic practice, maintaining line patency with saline flushes, delivering the medication at the prescribed rate, and watching for reactions. Using aseptic technique prevents introducing infection into the bloodstream during a needle or catheter–based drug delivery. Flushing with saline before and after each med ensures the line remains patent, clears any residual medication from previous doses, and helps prevent drug–drug or line–related interactions. Administering the dose slowly per the order controls the rate to reduce the risk of adverse reactions, extravasation, or venous irritation. Monitoring for adverse reactions during and after the injection allows immediate action if issues arise, such as allergic responses or local/systemic effects. Choosing approaches that skip sterile technique, omit flushing, administer too quickly, or ignore comprehensive monitoring would increase infection risk, line occlusion or incompatibility problems, greater potential for harm from rapid administration, and delayed recognition of adverse effects.

Safe IV push technique hinges on aseptic practice, maintaining line patency with saline flushes, delivering the medication at the prescribed rate, and watching for reactions.

Using aseptic technique prevents introducing infection into the bloodstream during a needle or catheter–based drug delivery. Flushing with saline before and after each med ensures the line remains patent, clears any residual medication from previous doses, and helps prevent drug–drug or line–related interactions. Administering the dose slowly per the order controls the rate to reduce the risk of adverse reactions, extravasation, or venous irritation. Monitoring for adverse reactions during and after the injection allows immediate action if issues arise, such as allergic responses or local/systemic effects.

Choosing approaches that skip sterile technique, omit flushing, administer too quickly, or ignore comprehensive monitoring would increase infection risk, line occlusion or incompatibility problems, greater potential for harm from rapid administration, and delayed recognition of adverse effects.